Skip to main content
Have a personal or library account? Click to login
Etoposide Therapy for Recurrent Gliomas Cover

Etoposide Therapy for Recurrent Gliomas

Open Access
|Jun 1997

Full Article

The efficacy and toxicity of long-term salvage chemotherapy with oral etoposide was studied in 14 children with recurrent supratentorial gliomas at the Department of Neurosciences, University of California, San Diego. All children had received radiotherapy and nitrosourea chemotherapies previously. MRI showed either a partial response or stable disease over a median duration of 8 months in 7 (50%). Toxic effects included alopecia (8 children), diarrhea (6), weight loss (4), anemia (4), neutropenia (4), and thrombocytopenia (4). [1]

COMMENT. Etoposide appears to be of some value in the salvage therapy of recurrent malignant supratentorial gliomas, and its toxicity is relatively low. This agent is also of value in the treatment of recurrent cerebellar gliomas. [2]

Language: English
Page range: 48 - 48
Published on: Jun 1, 1997
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 1997 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.